Clinical Trial Update: A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

A dose-finding study of inhaled OligoG vs placebo in cystic fibrosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• OligoG (oligoG)

Snippet

Sponsor: AlgiPharma AS | Conditions: Cystic Fibrosis | Phase 2, Phase 3 | Status: WITHDRAWN